Hepatitis, liver cirrhosis, and hepatocellular carcinoma
are all
manifestations of chronic hepatitis B. Its pathogenesis and molecular
mechanism remain mysterious. As medical science progresses, different
models are being used to study the disease from the physiological
and molecular levels. Animal models have played an unprecedented role
in achieving in-depth knowledge of the disease while posing no risk
of harming humans throughout the study. The scarcity of acceptable
animal models has slowed progress in hepatitis B virus (HBV) research
and preclinical testing of antiviral medicines since HBV has a narrow
species tropism and exclusively infects humans and higher primates.
The development of human chimeric mice was supported by a better understanding
of the obstacles to interspecies transmission, which has substantially
opened the way for HBV research in vivo and the evaluation
of possible chronic hepatitis B therapeutics. Animal models are cumbersome
to handle, not accessible, and expensive. Hence, it is herculean
to investigate the HBV replication cycle in animal models. Therefore,
it becomes essential to build a splendid in vitro cell culture system to demonstrate the mechanisms attained by the
HBV for its multiplication and sustenance. We also addressed the advantages
and caveats associated with different models in examining HBV.